A research team led by Professor Yoon Chae-ok (Department of Bio Engineering) of Hanyang University jointly conducted research with GC Labcell and  recently published the pre-clinical trial results for a natural killer (NK) cell treatment (MG4101) for pancreatic cancer.

Considering that an accumulation of extracellular fluid limits the penetration of the treatment into tumors in the case of pancreatic cancer, MG4101 provides a successful outcome in that it efficiently penetrates the tumor and rapidly removes it through cell death and reduction of immunosuppressive factors.

According to the director of GC Labcell, "This study has reaffirmed the possibility of NK cell therapy treating various types of cancer."



Jeon Chae-yun        global@hanyang.ac.kr